Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
- Resource Type
- Article
- Authors
- Piccioni, David E.; Selfridge, Julia; Mody, Reema R.; Chowdhury, Reshmi; Li, Sichen; Lalezari, Shadi; Wawrzynski, James; Quan, Jennifer; Zurayk, Mira; Chou, Arthur P.; Sanchez, Desiree E.; Liau, Linda M.; Ellingson, Benjamin M.; Pope, Whitney B.; Nghiemphu, Phioanh L.; Green, Richard M.; Wang, He-jing; Yong, William H.; Elashoff, Robert; Cloughesy, Timothy F.
- Source
- Neuro-Oncology; Jun2014, Vol. 16 Issue 6, p815-822, 8p
- Subject
- Language
- ISSN
- 15228517